tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
OVID is currently covered by 2 analysts with an average price target of $6.36. This is a potential upside of $4.6 (261.36%) from yesterday's end of day stock price of $1.76.
Ovid Therapeutics's activity chart (see below) currently has 52 price targets and 41 ratings on display. The stock rating distribution of OVID is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 10.16% with an average time for these price targets to be met of 39.63 days.
Highest price target for OVID is $2, Lowest price target is $2, average price target is $2.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Dec-2025. First documented stock forecast 30-May-2017.
Currently out of the existing stock ratings of OVID, 5 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 29-Apr-2024
$2
$0.24 (13.64%)
$2
15 days ago
(22-Dec-2025)
0/11 (0%)
$0.53 (36.05%)
Buy
Since 05-Apr-2024
$8
9 months 25 days ago
(12-Mar-2025)
0/1 (0%)
$4.75 (146.15%)
Hold
Since 04-Mar-2021
$1.2
$-0.56 (-31.82%)
$3.5
1 years 6 months 19 days ago
(18-Jun-2024)
9/16 (56.25%)
$0.41 (51.90%)
281
Buy
Since 30-Apr-2024
$3
$1.24 (70.45%)
$9
1 years 6 months 19 days ago
(18-Jun-2024)
0/2 (0%)
$2.21 (279.75%)
Buy
Since 15-Nov-2018
$4
$2.24 (127.27%)
$12
4 years 8 months 17 days ago
(20-Apr-2021)
1/4 (25%)
$0.4 (11.11%)
36
What is OVID (Ovid Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on OVID (Ovid Therapeutics) with a proven track record?
Which analyst has the current lower performing score on OVID (Ovid Therapeutics) with a proven track record?
Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?
Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?
Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?
